| PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia I Govaerts, C Prieto, C Vandersmissen, O Gielen, K Jacobs, S Provost, ... Journal of Hematology & Oncology 14 (1), 97, 2021 | 11 | 2021 |
| Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia C Vandersmissen, C Prieto, O Gielen, K Jacobs, D Nittner, J Maertens, ... Haematologica 108 (9), 2507, 2023 | 1 | 2023 |
| Resistance to PSEN1-selective γ-secretase inhibitors in T-cell acute lymphoblastic leukemia C Vandersmissen, S Demeyer, K Jacobs, L Boogaerts, SG Fernández, ... bioRxiv, 2024.03. 01.582944, 2024 | | 2024 |
| P348: MRK-560 AND DEXAMETHASONE ARE SYNERGISTIC IN THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA C Vandersmissen, CP Fernàndez, O Gielen, K Jacobs, I Govaerts, ... HemaSphere 6, 248-249, 2022 | | 2022 |
